519 related articles for article (PubMed ID: 8771497)
41. Immunosuppressive agents in organ transplantation: past, present, and future.
Hong JC; Kahan BD
Semin Nephrol; 2000 Mar; 20(2):108-25. PubMed ID: 10746855
[TBL] [Abstract][Full Text] [Related]
42. The effect of artificial antigen-presenting cells with preclustered anti-CD28/-CD3/-LFA-1 monoclonal antibodies on the induction of ex vivo expansion of functional human antitumor T cells.
Zappasodi R; Di Nicola M; Carlo-Stella C; Mortarini R; Molla A; Vegetti C; Albani S; Anichini A; Gianni AM
Haematologica; 2008 Oct; 93(10):1523-34. PubMed ID: 18728033
[TBL] [Abstract][Full Text] [Related]
43. Immunosuppression by OKT3--induction of programmed cell death (apoptosis) as a possible mechanism of action.
Janssen O; Wesselborg S; Kabelitz D
Transplantation; 1992 Jan; 53(1):233-4. PubMed ID: 1531094
[No Abstract] [Full Text] [Related]
44. Cyclosporin-A and the OKT3 monoclonal antibody exert their respective inhibitory and mitogenic activity on T cells by interacting with the same receptors.
Palacios R
J Clin Immunol; 1982 Jul; 2(3 Suppl):15S-19S. PubMed ID: 6982278
[TBL] [Abstract][Full Text] [Related]
45. Immunologic monitoring during OKT3 therapy.
Chatenoud L
Clin Transplant; 1993 Aug; 7(4 Pt 2):422-30. PubMed ID: 10146352
[TBL] [Abstract][Full Text] [Related]
46. OKT3: a monoclonal anti-human T lymphocyte antibody with potent mitogenic properties.
Van Wauwe JP; De Mey JR; Goossens JG
J Immunol; 1980 Jun; 124(6):2708-13. PubMed ID: 6966296
[TBL] [Abstract][Full Text] [Related]
47. Construction and characterization of a humanized anti-human CD3 monoclonal antibody 12F6 with effective immunoregulation functions.
Li B; Wang H; Dai J; Ji J; Qian W; Zhang D; Hou S; Guo Y
Immunology; 2005 Dec; 116(4):487-98. PubMed ID: 16313362
[TBL] [Abstract][Full Text] [Related]
48. Selective immunosuppression with anti-T cell monoclonal antibodies.
Chatenoud L; Bach JF
Clin Nephrol; 1992; 38 Suppl 1():S53-60. PubMed ID: 1295709
[TBL] [Abstract][Full Text] [Related]
49. Antibodies against functional leukocyte surface molecules in polyclonal antilymphocyte and antithymocyte globulins.
Bonnefoy-Bérard N; Vincent C; Revillard JP
Transplantation; 1991 Mar; 51(3):669-73. PubMed ID: 2006524
[TBL] [Abstract][Full Text] [Related]
50. The induction of human T cell unresponsiveness by soluble anti-CD3 mAb requires T cell activation.
Willems F; Andris F; Xu D; Abramowicz D; Wissing M; Goldman M; Leo O
Int Immunol; 1995 Oct; 7(10):1593-8. PubMed ID: 8562504
[TBL] [Abstract][Full Text] [Related]
51. Non-Fc receptor-binding humanized anti-CD3 antibodies induce apoptosis of activated human T cells.
Carpenter PA; Pavlovic S; Tso JY; Press OW; Gooley T; Yu XZ; Anasetti C
J Immunol; 2000 Dec; 165(11):6205-13. PubMed ID: 11086054
[TBL] [Abstract][Full Text] [Related]
52. Persistent long-term changes in lymphocyte subsets induced by polyclonal antibodies.
Müller TF; Grebe SO; Neumann MC; Heymanns J; Radsak K; Sprenger H; Lange H
Transplantation; 1997 Nov; 64(10):1432-7. PubMed ID: 9392307
[TBL] [Abstract][Full Text] [Related]
53. Monoclonal antibodies to CD3 as immunosuppressants.
Chatenoud L; Bach JF
Semin Immunol; 1990 Nov; 2(6):437-47. PubMed ID: 2151769
[TBL] [Abstract][Full Text] [Related]
54. Immunomodulation of T cells by thymic hormone and monoclonal anti-T cell antibody.
Bach JF; Dardenne M; Chatenoud L
Transplant Proc; 1982 Sep; 14(3):509-12. PubMed ID: 6758237
[No Abstract] [Full Text] [Related]
55. Nashville antithymocyte serum: a safe and efficacious agent for prophylaxis after heart transplantation.
Frist WH; Merrill WH; Eastburn TE; Stewart JR; Hammon JW; Fortune DS; Guy TS; Bender HW
Transplant Proc; 1991 Feb; 23(1 Pt 2):1160-1. PubMed ID: 1846455
[No Abstract] [Full Text] [Related]
56. Modulation induction of the T3 antigen by OKT3 antibody is monocyte dependent.
Rinnooy Kan EA; Platzer E; Welte K; Wang CY
J Immunol; 1984 Dec; 133(6):2979-85. PubMed ID: 6436370
[TBL] [Abstract][Full Text] [Related]
57. In vivo - in vitro correlates of antithymocyte globulin (ATG) immunosuppression in the human.
Thomas F; Berry R; Mendez-Picon G; Thomas J; Lower RR; Lee HM
Proc Clin Dial Transplant Forum; 1978 Nov 18-20; 8():56-61. PubMed ID: 386321
[No Abstract] [Full Text] [Related]
58. Activation of human B lymphocytes induced by Robinia pseudoacacia lectin in the presence of T cells.
Sharif A; Lethibichthuy ; Brochier J; Goussault Y; Bourrillon R
Immunology; 1978 Oct; 35(4):643-9. PubMed ID: 309432
[TBL] [Abstract][Full Text] [Related]
59. Treatment of acute rejection with anti-T-cell antigen receptor complex alpha beta (T10B9.1A-31) or anti-CD3 (OKT3) monoclonal antibody: results of a prospective randomized double-blind trial.
Waid TH; Lucas BA; Thompson JS; Munch LC; Brown S; Kryscio R; Prebeck R; VanHoy MA; Jezek D
Transplant Proc; 1991 Feb; 23(1 Pt 2):1062-5. PubMed ID: 1899152
[No Abstract] [Full Text] [Related]
60. Humanization of the murine anti-human CD3 monoclonal antibody OKT3.
Adair JR; Athwal DS; Bodmer MW; Bright SM; Collins AM; Pulito VL; Rao PE; Reedman R; Rothermel AL; Xu D
Hum Antibodies Hybridomas; 1994; 5(1-2):41-7. PubMed ID: 7858182
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
